BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 2998993)

  • 1. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Steel CM; Morten JE; Foster E
    IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
    Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
    Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
    Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
    Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics of Burkitt's lymphoma-leukaemia: a review.
    Berger R; Bernheim A
    IARC Sci Publ; 1985; (60):65-80. PubMed ID: 2998996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma?].
    Berger R; Bernheim A
    C R Acad Sci III; 1984; 298(6):143-5. PubMed ID: 6324967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome aberrations acquired in vitro by human B-cell lines. II. Distribution of break points.
    Shade M; Woodward MA; Steel CM
    J Natl Cancer Inst; 1980 Jul; 65(1):101-9. PubMed ID: 6967123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
    Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
    J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
    Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines.
    Harris A; Walsh-Arrand JE; Crawford DH; Lenoir GM; Griffin BE
    Mol Biol Med; 1984 Apr; 2(2):135-50. PubMed ID: 6099862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology and serology of Epstein-Barr virus (EBV) infections.
    Klein G
    Bull Cancer; 1976; 63(3):399-410. PubMed ID: 187269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion.
    Thielen C; Herens C; Fassotte MF; Detrooz E; Drion P; Diss T; Boniver J; de Leval L
    Eur J Haematol; 2006 Oct; 77(4):318-26. PubMed ID: 16856916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of tumorigenicity in an EBV-converted Burkitt's lymphoma line.
    Klein G
    Ciba Found Symp; 1989; 142():36-48; discussion 48-53. PubMed ID: 2545422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B-lymphoid cell lines.
    Nilsson K
    Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of lymphomatous cell lines from bone marrow samples from patients with Burkitt's lymphoma.
    Philip I; Philip T; Favrot M; Vuillaume M; Fontaniere B; Chamard D; Lenoir GM
    J Natl Cancer Inst; 1984 Oct; 73(4):835-40. PubMed ID: 6090749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma.
    Zunino A; Viaggi S; Ottaggio L; Fronza G; Schenone A; Roncella S; Abbondandolo A
    Haematologica; 2000 Mar; 85(3):250-5. PubMed ID: 10702812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic potential of Epstein-Barr virus.
    Lam KM; Crawford DH
    Crit Rev Oncog; 1991; 2(3):229-45. PubMed ID: 1653621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
    Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
    Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.